Neoadjuvant radiochemotherapy with paclitaxel and carboplatin in patients with non-small-cell lung cancer (stage III) - A phase-II study

被引：0
|
作者：
Budach, W
Friedel, G
Hehr, T
Sepe, S
Hruska, D
Toomes, H
Dierkesmann, R
Bamberg, M
机构：
[1] Univ Tubingen, Radioonkol Klinikum, Tubingen, Germany
[2] Thoraxchirurg Schillerhohe Gerlingen, Gerlingen, Germany
[3] Pulmol Schillerhohe Gerlingen, Gerlingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2002年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] PHASE-II STUDY OF CARBOPLATIN IN SMALL CELL LUNG-CANCER
    TAMURA, T
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    SAKURAI, M
    FUJIWARA, Y
    NAKANO, H
    NAKAGAWA, K
    MINATO, K
    HONG, WS
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1988, 18 (01) : 27 - 32
  • [42] Carboplatin and paclitaxel for previously treated patients with non-small-cell lung cancer
    Roa, V
    Conner, A
    Mitchell, RB
    CANCER INVESTIGATION, 1998, 16 (06) : 381 - 384
  • [43] Concurrent radiochemotherapy with carboplatin and paclitaxel followed by consolidation chemotherapy in patients with inoperable stage III non-small cell lung cancer (NSCLC)
    Serdar, Ozkok
    Dubova, S.
    Guersel, C.
    Yalman, D.
    T Goeksel
    Goker, E.
    LUNG CANCER, 2006, 52 : S41 - S41
  • [44] Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung Cancer
    Soria, Jean-Charles
    Mark, Zsuzsanna
    Zatloukal, Petr
    Szima, Barna
    Albert, Istvan
    Juhasz, Erzsebet
    Pujol, Jean-Louis
    Kozielski, Jerzy
    Baker, Nigel
    Smethurst, Dominic
    Hei, Yong-jiang
    Ashkenazi, Avi
    Stern, Howard
    Amler, Lukas
    Pan, Yang
    Blackhall, Fiona
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4442 - 4451
  • [45] Paclitaxel, carboplatin, and G-CSF in advanced non-small-cell lung cancer:: A phase I/II study
    Hübel, K
    Engert, A
    Schmitz, S
    Re, D
    Wassermann, K
    Ko, Y
    Schwandt, C
    Vetter, H
    Diehl, V
    Tesch, H
    ONKOLOGIE, 1998, 21 (04): : 310 - 314
  • [46] Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small-cell lung cancer(NSCLC)
    Kisohara, Akira
    Takahashi, Noriaki
    Tsujino, Ichirou
    Sato, Maki
    Horie, Takashi
    ANNALS OF ONCOLOGY, 2004, 15 : 180 - 180
  • [47] A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer
    Bogart, Jeffrey A.
    Govindan, Ramaswamy
    CLINICAL LUNG CANCER, 2006, 7 (04) : 285 - 287
  • [48] A phase II study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage III non-small-cell lung cancer
    Jeremic, B
    Shibamoto, Y
    Milicic, B
    Milisavljevic, S
    Nikolic, N
    Dagovic, A
    Aleksandrovic, J
    Radosavljevic-Asic, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (02): : 343 - 348
  • [49] Concurrent radiochemotherapy with ifosfamide in unresectable stage III non-small-cell lung cancer
    Schraube, P
    Latz, D
    Manegold, C
    Bischoff, H
    Krempien, R
    Pressler, K
    Wannenmacher, M
    Drings, P
    ONKOLOGIE, 1998, 21 (01): : 57 - 62
  • [50] Endostar in combination with radiotherapy and paclitaxel/carboplatin in patients with unresectable non-small cell lung cancer of stage III: Preliminary results of a phase II study
    Ma, S.
    Xu, Y.
    Sun, X.
    Ji, Y.
    Zheng, Y.
    Wang, S.
    Chen, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345